Lipid A, the endotoxic component of lipopolysaccharide of gram-negative bacteria, anchors the core and 0-antigen sugars to the outer membrane. The structure of this unusual lipid has been determined for a variety of species. In members of the family Enterobacteriaceae, such as Escherichia coli (16, 25) , Salmonella typhimurium (24) , Proteus mirabilis (20) , and Serratia marcescens (1), R-3-hydroxymyristoyl moieties are found in the 2,2' (N-linked) and 3,3' (0-linked) positions of the glucosamine disaccharide. In other gram-negative organisms, such as Pseudomonas aeruginosa (9) , Rhodobacter (Rhodopseudomonas) sphaeroides (15, 19) , and Neisseria gonorrhoeae (23) , the 0-and N-linked fatty acids have been found to differ. Another member of the Neisseria-Moraxella family, Acinetobacter calcoaceticus, has been reported to contain 0-and N-linked 3-hydroxylaurate (27) . The acyl groups attached directly to the glucosamine disaccharide of these types of lipid A are summarized in Table 1. UDP-N-acetylglucosamine-O-acyltransferase has been shown to catalyze the first committed step of lipid A biosynthesis (3). The enzyme from E. coli has been purified to homogeneity and extensively characterized (Sb). Its structural gene, lpxA, has been cloned and sequenced (6, 7) . Of particular interest is the fact that the enzyme is very specific for R-3-hydroxymyristoyl-acyl carrier protein (ACP) as the acyl donor. The product of O-acyltransferase activity, UDP-3-O-[(R)-3-hydroxymyristoyl]-GlcNAc, is then deacylated, and the second R-3-hydroxymyristoyl residue is added to the nitrogen of the glucosamine (Fig. 1) . The enzymes responsible for these transformations have been demonstrated in extracts of E. coli but have not yet been purified (4) . This pathway has not been studied in organisms other than E. coli and S. typhimurium (16) . We wanted to determine whether similar enzymes are present in organisms of clinical interest and whether the acyl-ACP specificity of the 0-and N-acyltransferases in vitro correlates with the characteristic fatty acids found in the lipid A of a particular gram-negative bacterium in vivo.
Cultures (26) . E. coli, Enterobacter aerogenes, P. aeruginosa, Klebsiella oxytoca, Citrobacter freundii, P. mirabilis, and A. calcoaceticus were grown at 37°C. The strains of S. marcescens were grown at 30°C. The cells were harvested by centrifugation, washed once in 0.9% NaCl, and suspended in 3.0 ml of HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid) sodium buffer (pH 7.5) containing DNase 11 (700 U) and a mixture of protease inhibitors (17 ,ug each of leupeptin, antipain, chymostatin, and pepstatin A per ml). Preparations of cell extracts were carried out at 2 to 4°C. The cells were ruptured by one passage in a French press at 18,000 lb/in2. Insoluble material was removed by centrifugation at 100,000 X gav for 90 min. The supernatant solutions were stored at -80°C until assayed. Protein concentration was determined by using the bicinchoninic acid method with bovine serum albumin as the standard (21) .
Preparation of acyl-ACPs. ACP was prepared from E. coli K-12 (1 kg; Grain Processing, Muscatine, Iowa) as described previously (18) . Acyl-ACP synthetase was prepared from E. coli K-12 as described previously (17) and used immobilized on Blue Sepharose to prepare the acyl-ACPs (3). The 10-and 12-carbon hydroxy acids are much poorer substrates for acyl-ACP synthetase than is the 14-carbon hydroxy acid. Quantitative acylation of ACP was obtained with R-3-hydroxymyristate. Its concentration was determined by titration with 5,5'-dithiobis(2-nitrobenzoic acid) as described previously (3) . About 20 to 30% acylation of ACP with RS-3-hydroxylaurate or RS-3-hydroxydecanoate was obtained. The concentrations of these acyl-ACPs were estimated by comparison with standards of known concentration after polyacrylamide gel electrophoresis as described previously (11) .
Preparation of 3-hydroxy fatty acids. 3-Ketodecanoate, 3-ketolaurate, and 3-ketomyristate methyl esters were pre- SepPak cartridge (Waters Associates; prepared for use by scheme has been presented previously (16) . U, uridine. the addition of 1.0 ml of 10 mM sodium HEPES (pH 8.0). The diluted reaction mixtures were loaded onto individual C18 SepPak cartridges (Waters Associates), and the products were determined as described previously (8) . Reactions containing 32p were stopped by spotting a portion (5 pul) of each mixture on a 20-by 20-cm silica gel plate, and the products were determined as described previously (3) . R-3-OHC14, R-3-hydroxymyristoyl-ACP; RS-3-OHC12, RS-3-hydroxylauroyl-ACP; RS-3-OHC10, RS-3-hydroxydecanoyl-ACP. b Determined with the SepPak assay. 'Determined by using thin-layer chromatography.
washing with 10 ml of methanol, 10 ml of water, and 10 ml of 10 mM bis-Tris buffer). The column and cartridge were washed with 30 ml of 200 mM NaCl. The SepPak cartridge (to which the desired product was bound) was removed from the column and attached to an empty syringe. The cartridge was washed with 30 ml of distilled water. Methanol was then used to elute the monoacylated product. All fractions containing radioactivity were combined and taken to dryness under a stream of nitrogen. The residue was dissolved in 0.1 ml of 10 mM sodium HEPES (pH 8.0) and used immediately. The average yield of purified product obtained (in seven trials; calculated from the amount of acyl-ACP added) was 62% + 12%.
Acyl-ACP specificity of UDP-GlcNAc-O-acyltransferase in various bacteria. Most had some activity with RS-3-hydroxylauroyl-ACP but much less with RS-3-hydroxydecanoyl-ACP. In the absence of octyl glucoside (an inhibitor of the deacetylase) and with R-3-hydroxymyristoyl-ACP as acyl donor, conditions that in E. coli are known to permit the action of the deacetylase and N-acyltransferase (4) , the time-dependent formation of UDP-2,3-diacyl-GlcN and the monoacylated product was found with all of these extracts (data not shown). In contrast, all strains of P. aeruginosa and R. sphaeroides utilized RS-3-hydroxydecanoyl-ACP most efficiently, but only the synthesis of the monoacylated material was observed. Finally, the two Acinetobacter strains utilized RS-3-hydroxylauroyl-ACP most efficiently.
Specificity of UDP-3-0-(3-hydroxyacyl)-GlcN-N-acyltransferase in various bacteria. Next, we wanted to determine the acyl-ACP specificities of the N-acyl transferases. This was more complicated than the previous work with the 0-acyltransferase, since the substrate required, UDP-3-0-[(R)-3-hydroxymyristoyl]-GlcNAc, is somewhat unstable (4) and the overall rate of reaction depends on the activity of both the deacetylase and N-acyltransferase. To minimize stability problems with the substrate, initial experiments were done with UDP-3-0-[(R)-3-hydroxymyristoyl]-GlcNAc, generated by incubation of a 10-fold molar excess of UDP-GlcNAc over that of R-3-hydroxymyristoyl-ACP with purified E. coli UDP-GlcNAc-0-acyltransferase and used without further purification. Under these conditions, all of the R-3-hydroxymyristoyl-ACP is utilized to form UDP-3-0-[(R)-3-hydroxymyristoyl]-GlcNAc. This mixture was incubated with the supernatant fraction of late-log-phase cells in the presence of different acyl donors. With extracts of all of the Enterobacteriaceae and A. calcoaceticus, there was substantial synthesis of UDP-2,3-diacyl-GlcN in the absence of any added acyl-ACP. The addition of R-3-hydroxymyristoyl-ACP gave, at best, a twofold stimulation of the activity (data not shown).
Purification of the UDP-3-0-[(R)-3-hydroxymyristoyl]-
GlcNAc away from ACP and UDP-GIcNAc-0-acyltransferase was found to remove most of the apparent N-acylation activity in the absence of acyl donor (data not shown). Therefore, the experiments on acyl-ACP specificities of these N-acyltransferases were repeated with purified substrate (Table 3) . In E. coli, K. oytoca, C. freundii, P. mirabilis, S. marcescens, and E. aerogenes, R-3-hydroxymyristoyl-ACP was the preferred acyl donor. However, substantial activity was still observed with RS-3-hydroxylauroyl-ACP or even RS-3-hydroxydecanoyl-ACP.
In contrast to the results with the Enterobacteriaceae, extracts of P. aeruginosa (Table 4) showed only a low level of UDP-2,3-diacyl-GlcN synthesis when provided with unpurified UDP-3-0-[(R)-3-hydroxymyristoyl]-GlcNAc in the absence of added acyl-ACP. The most efficient acyl donor was RS-3-hydroxylauroyl-ACP. When these experiments were repeated with purified substrate, the same relative results were obtained (data not shown). When a similar experiment was done with extracts of R. sphaeroides, no synthesis of UDP-2,3-diacyl-GlcN was observed under any condition, although monoacyl-UDP-GlcNAc formation was obtained when RS-3-hydroxydecanoyl-ACP was added to the reaction mixture (data not shown).
Since no 0-acyltransferase activity had been seen in the absence of an added acyl donor, it seemed unlikely that the N-acylation activity observed without acyl donor addition could be due to acyl-ACP contamination of the extracts. Therefore, an experiment was performed with an Enterobacter extract to determine which of the components of the 0-acylation reaction used to generate the substrate were required to obtain N acylation in the absence of added acyl-ACP (Fig. 2) . It obtained when ACP and the purified O-acyltransferase were added together. These data and the fact that purified and unpurified substrates gave the same results in Pseudomonas extracts suggested that UDP-GlcNAc-O-acyltransferase catalyzes the back reaction, the conversion of monoacyl-UDPGlcNAc and ACP to UDP-GlcNAc and acyl-ACP. Since the monoacyl-UDP-GlcNAc added to the Pseudomonas extract contained R-3-hydroxymyristate, the back reaction could only generate R-3-hydroxymyristoyl-ACP, which is not an effective acyl-donor for either the 0-or N-acyltransferases of this organism. To test this question directly, purified E. coli UDP-GlcNAc-O-acyltransferase was incubated with [at-32P]UDP-3-O-(R-3-hydroxymyristoyl)-GlcNAc and ACP, and the synthesis of UDP-GlcNAc was monitored as a function of time (Table 5 ). Substantial reversal of the reaction was found.
All of the results obtained on the acyl-ACP specificities of the UDP-GlcNAc-O-acyltransferases are consistent with the conclusion that it is the substrate specificity of this enzyme that determines the characteristic acyl group found in the 3,3' positions of the organism's lipid A. The results on the acyl-ACP specificity of the N-acyltransferase are also generally consistent with the conclusion that its specificity determines the nature of the acyl group found in the 2,2' position of lipid A. The only exception found thus far is A. calcoaceticus, which has been reported to contain 2,2' 3-hydroxylaurate (27) but whose specificity in vitro is for R-3-hydroxymyristoyl-ACP. The reason for this discrepancy is unknown. However, in light of these results and the fact that another member of the same family, N. gonorrhoeae, has been found to contain N-linked R-3-hydroxymyristate (23), it may be that the nature of the N-linked fatty acid in A. calcoaceticus warrants reinvestigation. Acyl-ACP dependence of the N-acyltransferase reaction in extracts of the species of Enterobacteriaceae and A. calcoaceticus could not be demonstrated when UDP-3-0-[(R)-3-hydroxymyristoyl]-GlcNAc was added to the extracts along with ACP and purified E. coli UDP-GlcNAc-0-acyltransferase. This result suggested that the 0-acyltransferase can catalyze the reverse reaction, the formation of R-3-hydroxymyristoyl-ACP and UDP-GlcNAc, in the presence of UDP-3.0-[(R)-3-hydroxymyristoyl]-GlcNAc and ACP (Fig. 1) . The results of the reconstruction experiment (Fig. 2) are consistent with this hypothesis; the addition of both ACP and 0-acyltransferase is required for maximum UDP-2,3-diacyl-GlcN formation in the absence of preformed R-3-hydroxymyristoyl-ACP. The reversibility of the reaction catalyzed by UDP-GlcNAc-0-acyl-transferase was then demonstrated directly with the purified enzyme ( Table 5) . Taken together, these results imply that R-3-hydroxymyristoyl-ACP (a thioester) is more stable than the product, UDP-3-0-(R-3-hydroxymyristoyl)-GlcNAc (an oxygen ester). This anomaly might be explained by the relatively low pKa of sugar hydroxyls and possible steric constraints at the 3 position (5c). Prolonged incubation of UDP-3-0-(R-3-hydroxymyristoyl)-GIcNAc in water at room temperature has been shown to result in migration of the 3-0-acyl moiety to the 6 position (4).
The fact that UDP-3-0-[(R)-3-hydroxymyristoyl]-GlcNAc serves as a substrate for the deacetylases and N-acyltransferases of P. aeruginosa and A. calcoaceticus, whose lipid A-s contain 0-linked fatty acids other than R-3-hydroxymyristate, implies that the deacetylase and N-acyltransferase from these organisms are relatively nonspecific with respect to the nature of the acyl group at the 3 position. It is puM [ct-32PJUDP-3-O-(R-3-hydroxymyristoyl)-GlcNAc (6.25 x 106 cpm/nmol), 1 p.M ACP (reduced with dithiothreitol before the reaction), 1 mg of bovine serum albumin (fatty acid free) per ml, 100 mM sodium HEPES (pH 7.5), and 24 nM UDP-GIcNAc-O-acyltransferase (treated with 1 mM dithiothreitol in the presence of 1 mg of bovine serum albumin per ml and 100 mM sodium HEPES [pH 7.5] immediately before use to insure maximum activity [5a] ). Incubation was at 30°C. At the indicated times, the reaction was stopped by spotting a portion (4 pul) of the reaction mixture directly onto a silica gel thin-layer plate. The plate was developed in chloroform-methanol-acetic acid-water (25/15/2/4, vol/vol), and the products were determined as previously described (3).
Lipid A molecules from a number of species of bacteria have been reported to contain branched, odd-chain-length, or extremely long-chain fatty acids (10, 13, 22, 27) . Because of the difficulty of preparing the acyl-ACP derivatives of these acids, we have not attempted to study the acyl transferases of these organisms. However, based on the results presented here, we would anticipate that the addition of the appropriate acyl-ACP would be required to detect 0-and N-acyltransferase activity. In organisms known to contain only R-3-hydroxymyristate, -laurate, or -decanoate, however, it should be possible to determine the positions of acyl substitution in lipid A by studying the acyl-ACP specificity of the 0-and N-acyltransferases in cell extracts. Finally, these results with clinically important gram-negative bacteria establish the generality of the lipid A biosynthetic pathway and its potential as a target for the development of novel antibacterials.
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